CANCER CONTROL NRG-CC04

Study #NRG-CC04

Breast or Gynecologic: Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire in Women with Breast or Gynecologic Cancer

Back To Clinical Trials